| scholarly article | Q13442814 |
| P50 | author | Maria Lina Tornesello | Q42245828 |
| Riccardo Bomben | Q52579044 | ||
| Gianfranco Lauletta | Q56761615 | ||
| Laura Caggiari | Q63869432 | ||
| Cesare Mazzaro | Q63869434 | ||
| Valli De Re | Q70466446 | ||
| Mariangela De Zorzi | Q83015415 | ||
| Fabio Pavone | Q117519284 | ||
| Riccardo Dolcetti | Q37378489 | ||
| Sabino Russi | Q38326899 | ||
| Francesco Izzo | Q38545877 | ||
| Anna Linda Zignego | Q39507303 | ||
| Laura Gragnani | Q40130918 | ||
| Paolo De Paoli | Q42133616 | ||
| P2093 | author name string | Massimiliano Berretta | |
| Pietro Casarin | |||
| Franco Maria Buonaguro | |||
| Salvatore De Vita | |||
| Marta Miorin | |||
| Vito Racanelli | |||
| Emanuela Vaccher | |||
| Luca Quartuccio | |||
| Elisa Fognani | |||
| Giancarlo Basaglia | |||
| Michela Ghersetti | |||
| Elena Garlatti Costa | |||
| P2860 | cites work | A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus | Q24307721 |
| Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance | Q28255243 | ||
| Endoplasmic reticulum stress activates the hepatic activator protein 1 complex via mitogen activated protein kinase-dependent signaling pathways | Q28391490 | ||
| An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity | Q28510917 | ||
| Dysregulation of toll-like receptor (TLR) 2 expression on monocytes and upregulation of the frequency of T cells expressing TLR2 in patients with chronic hepatitis C virus infection | Q42985297 | ||
| Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients | Q43001830 | ||
| Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma. | Q43030441 | ||
| IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy. | Q43031816 | ||
| Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. | Q43033205 | ||
| The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C. | Q43036140 | ||
| Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype. | Q43037497 | ||
| In vivo liver expression of TLR2, TLR3 and TLR7 in chronic hepatitis C. | Q50191564 | ||
| Interferon lambda 3 rs12979860 polymorphism in patients with haemophilia and HCV infection: a predictor of spontaneous viral clearance and sustained virological response. | Q51849759 | ||
| Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice. | Q53266736 | ||
| Toll-like receptor 2 -196 to 174del polymorphism influences the susceptibility of Japanese people to gastric cancer | Q80824228 | ||
| Genetic polymorphisms in the Toll-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer | Q88079954 | ||
| IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo | Q33325913 | ||
| IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. | Q34142463 | ||
| Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis | Q34321742 | ||
| IFN-λ4: the paradoxical new member of the interferon lambda family | Q34439917 | ||
| Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C. | Q34506224 | ||
| Antioxidant N-acetylcysteine attenuates hepatocarcinogenesis by inhibiting ROS/ER stress in TLR2 deficient mouse | Q35008938 | ||
| Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases. | Q35107234 | ||
| Activation and evasion of antiviral innate immunity by hepatitis C virus. | Q35606341 | ||
| The unique regulation and functions of type III interferons in antiviral immunity | Q35751815 | ||
| Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections | Q36073739 | ||
| IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction | Q36907926 | ||
| Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses | Q37352688 | ||
| Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents. | Q38135186 | ||
| Toll-like receptors and liver disease | Q38151944 | ||
| Interleukin 28B polymorphisms as predictor of response in hepatitis C virus genotype 2 and 3 infected patients | Q38174868 | ||
| Effect of IL28B genotype on hepatitis B and C virus infection | Q38568999 | ||
| Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation | Q40497000 | ||
| Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells | Q40584245 | ||
| Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3. | Q40982052 | ||
| Innate and Adaptive Immune Responses in Chronic HCV Infection | Q41035955 | ||
| TLR2 limits development of hepatocellular carcinoma by reducing IL18-mediated immunosuppression | Q41534407 | ||
| Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C: A phenotype-genotype correlation study | Q41711786 | ||
| Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection | Q42133572 | ||
| P433 | issue | 25 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toll-like receptor | Q408004 |
| P304 | page(s) | 37487-37497 | |
| P577 | publication date | 2016-05-11 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2. | |
| P478 | volume | 7 |
| Q47110542 | Association between genetic polymorphisms of the IL28B gene and leukomonocyte in Chinese hepatitis B virus-infected individuals |
| Q64086786 | Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma |
| Q98946923 | Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients |
| Q33706203 | Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma |
| Q52655112 | Hepatitis C Virus and Hepatocellular Carcinoma: Pathogenetic Mechanisms and Impact of Direct-Acting Antivirals. |
| Q37423627 | IL28B genotype is associated with cirrhosis or transition to cirrhosis in treatment-naive patients with chronic HCV genotype 1 infection: the international observational Gen-C study |
| Q99554960 | PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases |
| Q91981231 | Polymorphism in Toll-Like Receptors and Helicobacter Pylori Motility in Autoimmune Atrophic Gastritis and Gastric Cancer |
| Q90372490 | The influence of interleukin 28B polymorphisms on the risk of hepatocellular carcinoma among patients with HBV or HCV infection: An updated meta-analysis |
Search more.